Business Context and Reporting Period
This Form 8-K is a current report filed by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) on February 22, 2013. The filing addresses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure of director departure and does not contain financial performance data.
Material Changes
The material change disclosed is the decision by Marc N. Casper, a member of the Board of Directors, not to stand for re-election at the 2013 annual meeting of stockholders. The filing explicitly states this decision was not the result of any disagreement with the Company, management, or the Board.
Outlook and Management Commentary
- Transition Plan: Mr. Casper will continue to serve as a director and as a member of the Compensation and Management Development Committee and the Corporate Governance Committee until his term expires at the annual meeting on May 7, 2013.
- Board Structure: The Board intends to reduce its size to nine members effective upon the expiration of Mr. Casper's term.
- Risks and Contingencies: No specific risks, contingencies, or unusual items are disclosed in this filing.
Key Facts for Investor Verification
- Confirm the date of the 2013 annual meeting of stockholders (May 7, 2013).
- Verify the final composition of the Board of Directors following the expiration of Mr. Casper's term.
- Check subsequent filings for the election of any new directors to replace Mr. Casper, if applicable.